Use of human ultralente as the basal insulin component in treatment of patients with IDDM

Susan L. Freeman, Peter C. O'Brien, Robert A. Rizza

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Use of human ultralente as the basal insulin component in treatment of patients with IDDM'. Together they form a unique fingerprint.

Medicine & Life Sciences